SWP
IHE icon

Strategic Wealth Partners’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Strategic Wealth Partners’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-360
Closed -$16.8K – 301
2019
Q3 		$16.8K Buy
+360
New +$17.2K 0.09% 120

Other funds holding IHE

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Strategic Wealth Partners's IHE Position: Q4 2019 in Review

Strategic Wealth Partners sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2019, closing a stake of 360 shares — an estimated $16.8K sold.

Strategic Wealth Partners first reported a position in IHE in Q3 2019 and held it in 1 quarter. The position peaked at $16.8K in Q3 2019. 95 funds tracked by Wall St. Rank hold IHE as of Q4 2019.

  • Strategic Wealth Partners reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2019 after selling out during the quarter.
  • Strategic Wealth Partners sold 360 iShares US Pharmaceuticals ETF shares in Q4 2019, an estimated $16.8K.
  • Strategic Wealth Partners first reported a position in iShares US Pharmaceuticals ETF in Q3 2019 and held it in 1 quarter.
  • Strategic Wealth Partners's iShares US Pharmaceuticals ETF position peaked at $16.8K in Q3 2019.
  • 95 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2019.

Based on Strategic Wealth Partners's 13F filing for Q4 2019, filed 30 Jan 2020.